Compound ID | 3311
Class: Protein synthesis inhibitor
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Targets 50s ribosomal subunit |
| Target Pathogen: | Active against Staphylococcus aureus and Enterococcus faecalis |
| Description: | Natural product from Micrococcus luteus |
| Institute where first reported: | The Squibb Institute for Medical Research |
| Year first mentioned: | 1988 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.jstage.jst.go.jp/article/antibiotics1968/41/5/41_5_684/_article/-char/en |